Yang Du
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 2%
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications
Papers in
-
- Nanoplatforms for cancer theranostics 12
-
- Inflammasome and immune disorders 3
- Co-authors
- Fangyuan Li (10 shared papers)Daishun Ling (9 shared papers)Jie Tian (4 shared papers)Na Li (2 shared papers)Luru Dai (2 shared papers)Linlin Song (2 shared papers)Qian Zhang (2 shared papers)Baoquan Ding (2 shared papers)
- Journals
- Biomaterials (3 papers)ACS Nano (3 papers)Advanced Materials (3 papers)Small (3 papers)Journal of Building Engineering (2 papers)
- Partner nations
- ChinaUnited StatesNew Zealand
In The Last Decade
Yang Du
53 papers receiving 2.6k citations
Yang Du's Hit Papers
Peers
Comparison fields: 5 of 118
- Biomaterials 546
- Biomedical Engineering 1.0k
- Rehabilitation 122
- Molecular Biology 1.1k
- Materials Chemistry 644
Countries citing papers authored by Yang Du
This map shows the geographic impact of Yang Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Du more than expected).
Fields of papers citing papers by Yang Du
This network shows the impact of papers produced by Yang Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Du. The network helps show where Yang Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Yang Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | DNA Origami as an In Vivo Drug Delivery Vehicle for Cancer Therapy Hit paper breakdown → | 2014 | 536 |
| 2 | 2017 | 289 | |
| 3 | 2018 | 226 | |
| 4 | 2018 | 224 | |
| 5 | Mitochondrial‐Targeted Delivery of Polyphenol‐Mediated Antioxidases Complexes against Pyroptosis and Inflammatory Diseases Hit paper breakdown → | 2023 | 167 |
| 6 | 2016 | 112 | |
| 7 | 2019 | 99 | |
| 8 | 2015 | 95 | |
| 9 | 2021 | 67 | |
| 10 | 2018 | 67 | |
| 11 | 2018 | 56 | |
| 12 | 2022 | 51 | |
| 13 | 2014 | 49 | |
| 14 | 2023 | 39 | |
| 15 | 2024 | 34 | |
| 16 | 2020 | 32 | |
| 17 | 2019 | 32 | |
| 18 | 2015 | 31 | |
| 19 | 2013 | 30 | |
| 20 | 2018 | 26 |
About Yang Du
Yang Du is a scholar working on Biomedical Engineering, Molecular Biology, Materials Chemistry, Biomaterials and Pulmonary and Respiratory Medicine, having authored 55 papers that have together received 2.6k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (12 papers), Nanoparticle-Based Drug Delivery (6 papers), Botanical Studies and Applications (4 papers), Advanced Nanomaterials in Catalysis (4 papers), Photodynamic Therapy Research Studies (3 papers), Antioxidants, Aging, Portulaca oleracea (3 papers), Immune cells in cancer (3 papers) and Inflammasome and immune disorders (3 papers). The work is most often cited by research in Biomaterials (546 citations), Biomedical Engineering (1.0k citations), Rehabilitation (122 citations), Molecular Biology (1.1k citations) and Materials Chemistry (644 citations). Yang Du has collaborated with scholars based in China, United States and New Zealand. Frequent co-authors include Fangyuan Li, Daishun Ling, Jie Tian, Na Li, Luru Dai, Linlin Song, Qian Zhang, Baoquan Ding, Yaqian Li and Qiao Jiang. Their work appears in journals such as Biomaterials, ACS Nano, Advanced Materials, Small and Journal of Building Engineering.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.